HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts
Experts warn that new injectable HIV prevention treatment PrEP could significantly reduce global HIV cases. However, cuts in US foreign aid restrict access for high-need populations, limiting the drug's potential impact worldwide according to AIDS 2026 Conference attendees.
HIV PrEP lenacapavir US foreign aid HIV prevention